Nivolumab and ipilimumab in combination with radiotherapy in patients with locally advanced head and neck cancer

被引：0
|
作者：
Johnson, J. M. [1 ]
Bar Ad, V. [2 ]
Lorber, E. [1 ]
Luginbuhl, A. [3 ]
Curry, J. M. [3 ]
Cognetti, D. [3 ]
Keith, S. [4 ]
Axelrod, R. [1 ]
Zinner, R. [1 ]
Rodeck, U. [5 ]
Harshyne, L. A. [6 ]
Argiris, A. [7 ]
机构：
[1] Thomas Jefferson Univ, Dept Med Oncol, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Dept Radiat Oncol, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ, Dept Otolaryngol, 1721 Pine St, Philadelphia, PA 19103 USA
[4] Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA
[5] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA
[6] Thomas Jefferson Univ, Dept Neurosurg, Philadelphia, PA 19107 USA
[7] Hygeia Hosp, Med Oncol, Athens, Greece
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1126TiP
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Altered-fractionated radiotherapy in locally advanced head and neck cancer
    Bernier, Jacques
    Horiot, Jean-Claude
    CURRENT OPINION IN ONCOLOGY, 2012, 24 (03) : 223 - 228
  • [22] Alternating chemotherapy and radiotherapy in locally advanced head and neck cancer:: An alternative?
    Merlano, Marco
    ONCOLOGIST, 2006, 11 (02): : 146 - 151
  • [23] Hypofractionated Radiotherapy plus Cetuximab in Locally Advanced Head and Neck Cancer
    Teoh, D. C.
    Rodger, S.
    Say, J.
    Hartley, A.
    CLINICAL ONCOLOGY, 2008, 20 (09) : 717 - 717
  • [24] Causes of death in patients with locally advanced head and neck cancer treated with radiotherapy and systemic therapy
    Zapata, I
    Alvarez, M.
    Hidalgo, R.
    Pajares, B.
    Garcia-Anaya, M. J.
    Toledo, M. D.
    Trigo, J. M.
    Lupianez-Perez, Y.
    Medina, J. A.
    Jaime Gomez-Millan, J.
    BMC CANCER, 2019, 19 (01)
  • [25] Causes of death in patients with locally advanced head and neck cancer treated with radiotherapy and systemic therapy
    I. Zapata
    M. Alvarez
    R. Hidalgo
    B. Pajares
    M. J. Garcia-Anaya
    M. D. Toledo
    J. M. Trigo
    Y. Lupiañez-Perez
    J. A. Medina
    J. Jaime Gomez-Millan
    BMC Cancer, 19
  • [26] Accelerated postoperative radiotherapy with weekly concomitant boost in patients with locally advanced head and neck cancer
    Zouhair, A
    Azria, D
    Pasche, P
    Stupp, R
    Chevalier, J
    Betz, M
    Mirimanoff, RO
    Ozsahin, M
    RADIOTHERAPY AND ONCOLOGY, 2004, 70 (02) : 183 - 188
  • [27] Nivolumab (Nivo) and ipilimumab (Ipi) combined with radiotherapy (RT) in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN): Updated results of a pilot study
    Johnson, J. M.
    Ali, A.
    Lorber, E.
    Poller, D.
    Keith, S. W.
    Luginbuhl, A.
    Curry, J. M.
    Cognetti, D.
    Axelrod, R.
    Bar-Ad, V.
    Argiris, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S791 - S791
  • [28] Locally advanced head and neck cancer
    Kies M.S.
    Bennett C.L.
    Vokes E.E.
    Current Treatment Options in Oncology, 2001, 2 (1) : 7 - 13
  • [29] Cost-effectiveness of cetuximab in combination with radiotherapy versus radiotherapy alone in the treatment of locally advanced head and neck cancer in Spain
    Brosa, M.
    Robinson, P.
    Brown, B.
    VALUE IN HEALTH, 2006, 9 (06) : A281 - A281
  • [30] Feasibility of docetaxel-cisplatin combination chemoradicitherapy in the patients with locally advanced head and neck cancer
    Demiroz, C.
    Yilmaz, E.
    Cakir, S.
    Kurt, M.
    Ozkan, L.
    RADIOTHERAPY AND ONCOLOGY, 2007, 82 : S58 - S58
12345